Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.
2.

Increased Resilience is Associated with Positive Treatment Outcomes for Veterans with Comorbid PTSD and Substance Use Disorders.

McGuire AP, Mota NP, Sippel LM, Connolly KM, Lyons JA.

J Dual Diagn. 2018 Jul-Sep;14(3):181-186. doi: 10.1080/15504263.2018.1464237. Epub 2018 May 21.

PMID:
29668364
3.

The Role of Impulsivity Dimensions in the Relation Between Probable Posttraumatic Stress Disorder and Aggressive Behavior Among Substance Users.

Weiss NH, Connolly KM, Gratz KL, Tull MT.

J Dual Diagn. 2017 Apr-Jun;13(2):109-118. doi: 10.1080/15504263.2017.1293310. Epub 2017 Feb 8.

4.

The impact of changes in distress tolerance on PTSD symptom severity post-treatment among veterans in residential trauma treatment.

Banducci AN, Connolly KM, Vujanovic AA, Alvarez J, Bonn-Miller MO.

J Anxiety Disord. 2017 Apr;47:99-105. doi: 10.1016/j.janxdis.2017.01.004. Epub 2017 Jan 16.

PMID:
28109673
5.
6.

The impact of intolerance of emotional distress and uncertainty on veterans with co-occurring PTSD and substance use disorders.

Banducci AN, Bujarski SJ, Bonn-Miller MO, Patel A, Connolly KM.

J Anxiety Disord. 2016 Jun;41:73-81. doi: 10.1016/j.janxdis.2016.03.003. Epub 2016 Mar 9.

PMID:
27004450
7.

Diagnostic Concordance between DSM-5 and ICD-10 Cannabis Use Disorders.

Proctor SL, Williams DC, Kopak AM, Voluse AC, Connolly KM, Hoffmann NG.

Addict Behav. 2016 Jul;58:117-22. doi: 10.1016/j.addbeh.2016.02.034. Epub 2016 Feb 20.

PMID:
26922159
8.

The relation of PTSD symptoms to migraine and headache-related disability among substance dependent inpatients.

McDermott MJ, Fulwiler JC, Smitherman TA, Gratz KL, Connolly KM, Tull MT.

J Behav Med. 2016 Apr;39(2):300-9. doi: 10.1007/s10865-015-9697-3. Epub 2015 Nov 26.

PMID:
26611236
9.

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine.

Neafsey DE, Juraska M, Bedford T, Benkeser D, Valim C, Griggs A, Lievens M, Abdulla S, Adjei S, Agbenyega T, Agnandji ST, Aide P, Anderson S, Ansong D, Aponte JJ, Asante KP, Bejon P, Birkett AJ, Bruls M, Connolly KM, D'Alessandro U, Dobaño C, Gesase S, Greenwood B, Grimsby J, Tinto H, Hamel MJ, Hoffman I, Kamthunzi P, Kariuki S, Kremsner PG, Leach A, Lell B, Lennon NJ, Lusingu J, Marsh K, Martinson F, Molel JT, Moss EL, Njuguna P, Ockenhouse CF, Ogutu BR, Otieno W, Otieno L, Otieno K, Owusu-Agyei S, Park DJ, Pellé K, Robbins D, Russ C, Ryan EM, Sacarlal J, Sogoloff B, Sorgho H, Tanner M, Theander T, Valea I, Volkman SK, Yu Q, Lapierre D, Birren BW, Gilbert PB, Wirth DF.

N Engl J Med. 2015 Nov 19;373(21):2025-2037. doi: 10.1056/NEJMoa1505819. Epub 2015 Oct 21.

10.

Feeding practices of dog breeders in the United States and Canada.

Connolly KM, Heinze CR, Freeman LM.

J Am Vet Med Assoc. 2014 Sep 15;245(6):669-76. doi: 10.2460/javma.245.6.669.

PMID:
25181271
11.

Gender as a moderator of the relation between PTSD and disgust: a laboratory test employing individualized script-driven imagery.

Olatunji BO, Babson KA, Smith RC, Feldner MT, Connolly KM.

J Anxiety Disord. 2009 Dec;23(8):1091-7. doi: 10.1016/j.janxdis.2009.07.012. Epub 2009 Jul 14.

PMID:
19647980
12.

Evaluation of the Alcohol Craving Questionnaire-Now factor structures: application of a cue reactivity paradigm.

Connolly KM, Coffey SF, Baschnagel JS, Drobes DJ, Saladin ME.

Drug Alcohol Depend. 2009 Jul 1;103(1-2):84-91. doi: 10.1016/j.drugalcdep.2009.03.019. Epub 2009 May 6.

13.

Information processing in contamination fear: a covariation bias examination of fear and disgust.

Connolly KM, Lohr JM, Olatunji BO, Hahn KS, Williams NL.

J Anxiety Disord. 2009 Jan;23(1):60-8. doi: 10.1016/j.janxdis.2008.03.017. Epub 2008 Apr 7.

PMID:
18472392
14.
15.

Structural differentiation of disgust from trait anxiety in the prediction of specific anxiety disorder symptoms.

Olatunji BO, Williams NL, Lohr JM, Connolly KM, Cisler J, Meunier SA.

Behav Res Ther. 2007 Dec;45(12):3002-17. Epub 2007 Aug 19.

PMID:
17888397
16.

Scrupulosity and obsessive-compulsive symptoms: confirmatory factor analysis and validity of the Penn Inventory of Scrupulosity.

Olatunji BO, Abramowitz JS, Williams NL, Connolly KM, Lohr JM.

J Anxiety Disord. 2007;21(6):771-87. Epub 2006 Dec 30.

PMID:
17250990
17.

The Anxiety Sensitivity Profile revisited: factor structure and psychometric properties in two nonclinical samples.

Olatunji BO, Sawchuk CN, Deacon BJ, Tolin DF, Lilienfeld SO, Williams NL, Meunier SA, Lohr JM, Connolly KM.

J Anxiety Disord. 2005;19(6):603-25.

PMID:
15927776
18.

Impulsivity as a risk factor for eating disorder behavior: assessment implications with adolescents.

Wonderlich SA, Connolly KM, Stice E.

Int J Eat Disord. 2004 Sep;36(2):172-82.

PMID:
15282687
19.

Localization and mutagenesis of the sorting signal binding site on sortase A from Staphylococcus aureus.

Liew CK, Smith BT, Pilpa R, Suree N, Ilangovan U, Connolly KM, Jung ME, Clubb RT.

FEBS Lett. 2004 Jul 30;571(1-3):221-6.

20.

Sortase from Staphylococcus aureus does not contain a thiolate-imidazolium ion pair in its active site.

Connolly KM, Smith BT, Pilpa R, Ilangovan U, Jung ME, Clubb RT.

J Biol Chem. 2003 Sep 5;278(36):34061-5. Epub 2003 Jun 24.

21.

Regulation of directionality in bacteriophage lambda site-specific recombination: structure of the Xis protein.

Sam MD, Papagiannis CV, Connolly KM, Corselli L, Iwahara J, Lee J, Phillips M, Wojciak JM, Johnson RC, Clubb RT.

J Mol Biol. 2002 Dec 6;324(4):791-805.

PMID:
12460578
22.

Xis protein binding to the left arm stimulates excision of conjugative transposon Tn916.

Connolly KM, Iwahara M, Clubb RT.

J Bacteriol. 2002 Apr;184(8):2088-99.

23.

Avoiding intubation in the injured subglottis: the role of heliox therapy.

Connolly KM, McGuirt WF Jr.

Ann Otol Rhinol Laryngol. 2001 Aug;110(8):713-7.

PMID:
11510726
24.

Diagnostic laryngeal electromyography: The Wake Forest experience 1995-1999.

Koufman JA, Postma GN, Whang CS, Rees CJ, Amin MR, Belafsky PC, Johnson PE, Connolly KM, Walker FO.

Otolaryngol Head Neck Surg. 2001 Jun;124(6):603-6.

PMID:
11391248
25.
26.

Major groove recognition by three-stranded beta-sheets: affinity determinants and conserved structural features.

Connolly KM, Ilangovan U, Wojciak JM, Iwahara M, Clubb RT.

J Mol Biol. 2000 Jul 21;300(4):841-56.

PMID:
10891272
27.

NMR structure and functional studies of the Mu repressor DNA-binding domain.

Ilangovan U, Wojciak JM, Connolly KM, Clubb RT.

Biochemistry. 1999 Jun 29;38(26):8367-76.

PMID:
10387082
28.

Resonance assignments of the Tn916 integrase DNA-binding domain and the integrase:DNA complex.

Connolly KM, Wojciak JM, Clubb RT.

J Biomol NMR. 1999 May;14(1):95-6. No abstract available.

PMID:
10382314
29.

NMR structure of the Tn916 integrase-DNA complex.

Wojciak JM, Connolly KM, Clubb RT.

Nat Struct Biol. 1999 Apr;6(4):366-73.

PMID:
10201406
30.

Site-specific DNA binding using a variation of the double stranded RNA binding motif.

Connolly KM, Wojciak JM, Clubb RT.

Nat Struct Biol. 1998 Jul;5(7):546-50.

PMID:
9665166
31.

Introduction of a conformational switching element on a pyrrolidine ring. Synthesis and evaluation of (R*,R*)-(+/-)-methyl 3-acetyl-4-[3- (cyclopentyloxy)-4-methoxyphenyl]-3-methyl-1-pyrrolidinecarboxylate, a potent and selective inhibitor of cAMP-specific phosphodiesterase.

Stafford JA, Veal JM, Feldman PL, Valvano NL, Baer PG, Brackeen MF, Brawley ES, Connolly KM, Domanico PL, Han B, et al.

J Med Chem. 1995 Dec 22;38(26):4972-5. No abstract available.

PMID:
8544172
32.

A canine model for determination of the therapeutic index of cytokine inhibitors.

Sekut L, Han B, Baer P, Verghese MW, Silverstein R, Clifton L, Dennis S, Numerick MJ, Connolly KM.

Lab Anim Sci. 1995 Dec;45(6):647-51.

PMID:
8746524
33.

Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.

Sekut L, Yarnall D, Stimpson SA, Noel LS, Bateman-Fite R, Clark RL, Brackeen MF, Menius JA Jr, Connolly KM.

Clin Exp Immunol. 1995 Apr;100(1):126-32.

34.

Anti-inflammatory activity of salmeterol: down-regulation of cytokine production.

Sekut L, Champion BR, Page K, Menius JA Jr, Connolly KM.

Clin Exp Immunol. 1995 Mar;99(3):461-6.

35.
36.

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor.

McGeehan GM, Becherer JD, Bast RC Jr, Boyer CM, Champion B, Connolly KM, Conway JG, Furdon P, Karp S, Kidao S, et al.

Nature. 1994 Aug 18;370(6490):558-61.

PMID:
8052311
37.

Elevated levels of TNF in the joints of adjuvant arthritic rats.

Smith-Oliver T, Noel LS, Stimpson SS, Yarnall DP, Connolly KM.

Cytokine. 1993 Jul;5(4):298-304.

PMID:
8260594
39.

Differential effects of anti-arthritic agents on subnormal plasma iron levels in adjuvant arthritic rats.

Connolly KM, Stecher VJ, Speight PT, Becker R, Rathman J.

Agents Actions. 1989 Jun;27(3-4):328-31.

PMID:
2801318
40.

Elevation of plasma fibronectin and serum amyloid P in autoimmune NZB, B/W, and MRL/1pr mice.

Connolly KM, Stecher VJ, Rudofsky UH, Pruden DJ.

Exp Mol Pathol. 1988 Dec;49(3):388-94.

PMID:
3197816
41.

Lymphocyte activating factor (LAF) and the acute-phase response in adjuvant arthritic rats.

Connolly KM, Stecher VJ, Allin S, LaBrie T.

Exp Mol Pathol. 1988 Dec;49(3):348-60.

PMID:
3143600
42.

The effect of danazol in the MRL/lpr mouse model of autoimmune disease.

Connolly KM, Stecher VJ, Snyder BW, Bohnet E, Potts GO.

Agents Actions. 1988 Aug;25(1-2):164-70.

PMID:
3189043
43.

Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs.

Connolly KM, Stecher VJ, Danis E, Pruden DJ, LaBrie T.

Agents Actions. 1988 Aug;25(1-2):94-105.

PMID:
3142230
44.
45.
46.

Single-step purification of rat C-reactive protein and generation of monospecific C-reactive protein antibody.

Pruden DJ, Connolly KM, Stecher VJ.

J Chromatogr. 1988 Mar 25;437(2):399-410.

PMID:
3132479
47.
48.
49.

The effect of glucocorticoids on plasma fibronectin levels in normal and arthritic rats.

Stecher VJ, Connolly KM, Snyder BW.

Proc Soc Exp Biol Med. 1986 Jul;182(3):301-7.

PMID:
3714710
50.

Disease-modifying antirheumatic drugs.

Stecher VJ, Carlson JA, Connolly KM, Bailey DM.

Med Res Rev. 1985 Jul-Sep;5(3):371-90. Review. No abstract available.

PMID:
3894835

Supplemental Content

Loading ...
Support Center